Buying pressure lifts Tilray higher in today trading

Traders Union
All News
Financial News
Tilray rises 2.18% today to $7.75

Highlights

Tilray has secured a multi-year exclusive licensing agreement with Carlsberg Group to produce, market, and distribute Carlsberg beer brands in the U.S. starting January 1, 2027.
The five-year deal includes brands like Carlsberg, Carlsberg Elephant, Kronenbourg 1664, and leverages Tilray’s U.S.-based manufacturing for immediate entry into the U.S. beverage segment.
Technically, Tilray (TLRY) trades at $7.75 below key moving averages (MA-20, MA-50, MA-200), with short- and medium-term trend indicators signaling a bearish bias and downside risk toward $6.85.

Carlsberg partnership expands U.S. market access for Tilray

Tilray has signed an exclusive multi-year licensing agreement with the Carlsberg Group, giving it rights to produce, market, sell, and distribute several Carlsberg beer brands in the United States beginning January 1, 2027. The deal covers notable brands such as Carlsberg, Carlsberg Elephant, Kronenbourg 1664, and Kronenbourg 1664 Blanc, and will leverage Tilray’s U.S.-based manufacturing and sales operations. The partnership provides Tilray with immediate entry and potential scale in the U.S. beverage segment with an initial five-year term and further renewal options.

Anton Kharitonov, expert at Traders Union, sees Tilray Brands Inc. weighed down by persistent technical and fundamental weakness. The price sits well below all major moving averages, showing bears remain in control. Momentum is decisively negative, with trend signals failing to offer early reversal signs. Despite a notable licensing deal with Carlsberg, he views the news as insufficient to offset prevailing bearish sentiment or weak institutional support. "Investors should remain defensive while TLRY stays under key resistance levels and sellers dominate volume."

Viktoras Karapetjanc, expert at Traders Union, believes the exclusive Carlsberg licensing partnership marks a major strategic win for Tilray. He sees the U.S. beer market entry as a new growth engine, laying foundations for broader future expansion and brand diversification. Karapetjanc expects Tilray’s positioning and new alliances to drive substantial opportunities despite short-term price volatility. "This deal reinforces a bullish structure for TLRY and further growth is expected as execution ramps up toward 2027."

Jainam Mehta, market strategist, notes a mixed tactical outlook for TLRY. Technicals highlight bearish momentum yet also show pockets of intraday buying. With price near range lows and momentum indicators diverging, Mehta points to the potential for mean-reverting trades but prioritizes risk management. "A break above $8.55 could trigger short-term upside, but downside exposure dominates until support at $6.85 shows clear defense."

Bearish momentum sustained as mixed signals cap upside

TLRY’s price remains below its MA-20, MA-50, and MA-200, with the nearest resistance at the Ichimoku Kijun ($8.55) and no dynamic support directly below current levels, underlining continued seller pressure across technical horizons. Daily MACD readings point to firm bearish momentum, but the ADX shows weak trend strength. The RSI is close to 41, reflecting a bearish tilt, while the Stochastic RSI is overbought, the CCI is neutral, and BBP suggests the presence of intraday buyers. Overall, technical indicators provide a mixed momentum picture.

Last time, analysts noted that Tilray Brands Inc. continues to trade below all major moving averages, with negative momentum confirmed by weak MACD and RSI readings and dynamic resistance observed around $8.55. Technical signals show persistent bearish pressure and mild oversold conditions, with sellers maintaining control and no immediate reversal signs evident.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.